tiprankstipranks
Advertisement
Advertisement
Tenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401
PremiumThe FlyTenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401
2M ago
Tenaya Therapeutics: Buy Rating Reiterated on Upcoming Gene Therapy Catalysts and Unchanged $5 Price Target
Premium
Ratings
Tenaya Therapeutics: Buy Rating Reiterated on Upcoming Gene Therapy Catalysts and Unchanged $5 Price Target
2M ago
Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)
Premium
The Fly
Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100